seed
Stage
2
Investors
About
Stilla Technologies develops digital PCR systems that provide absolute quantification and multiplex analysis for genetic research and diagnostics applications.
Explore Stilla Technologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.